PLUS THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Plus Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Plus Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.8M, a 16.9% decline year-over-year.
  • Plus Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$14.7M, a 2.54% increase year-over-year.
  • Plus Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$13.3M, a 32.4% increase from 2022.
  • Plus Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$19.7M, a 57.8% decline from 2021.
  • Plus Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$12.5M, a 30.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$14.7M -$3.8M -$548K -16.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$14.1M -$3.7M -$2.21M -148% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$11.9M -$3.3M +$1.42M +30.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$13.3M -$3.86M +$1.71M +30.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$15M -$3.25M +$1.84M +36.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$16.9M -$1.49M +$3.63M +70.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$20.5M -$4.72M -$796K -20.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$19.7M -$5.57M -$1.63M -41.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$18.1M -$5.09M -$1.6M -45.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 -$16.5M -$5.12M -$2.55M -98.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$13.9M -$3.93M -$1.45M -58.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-20
Q4 2021 -$12.5M -$3.94M -$544K -16% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$11.9M -$3.5M -$2.1M -151% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-20
Q2 2021 -$9.85M -$2.58M -$223K -9.48% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-21
Q1 2021 -$9.62M -$2.48M -$38K -1.56% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-21
Q4 2020 -$9.58M -$3.4M -$1.18M -53.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$8.4M -$1.4M -$4.08M -152% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-21
Q2 2020 -$4.33M -$2.35M -$393K -20.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 -$3.93M -$2.44M -$275K -12.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 -$3.66M -$2.21M -$393K -21.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-22
Q3 2019 -$3.26M $2.68M +$4.91M Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-22
Q2 2019 -$8.17M -$1.96M -$113K -6.12% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$8.06M -$2.17M +$704K +24.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$8.76M -$1.82M -$7.79M -130% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$968K -$2.23M +$2.12M +48.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$3.08M -$1.85M +$3.74M +66.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 -$6.82M -$2.87M +$4.26M +59.7% Jan 1, 2018 Mar 31, 2018 8-K 2019-09-10
Q4 2017 -$11.1M $5.98M +$9.56M Oct 1, 2017 Dec 31, 2017 8-K 2019-09-10
Q3 2017 -$20.6M -$4.34M +$454K +9.46% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$21.1M -$5.58M +$643K +10.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$21.7M -$7.13M -$2.03M -39.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$19.7M -$3.59M -$1.51M -72.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$18.2M -$4.8M -$6.79M -340% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$11.4M -$6.22M -$12M -207% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $614K -$5.1M +$15.9M +75.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$15.3M -$2.08M +$2.24M +51.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 -$17.5M $2M +$9.89M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$27.4M $5.79M +$16.5M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 -$43.9M -$21M -$11.5M -120% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$32.4M -$4.32M +$4.8M +52.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$37.2M -$7.89M +$571K +6.75% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$37.8M -$10.7M -$4.32M -67.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$33.5M -$9.55M -$2.81M -41.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$30.7M -$9.12M -$6.36M -230% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 -$24.3M -$8.46M +$1.87M +18.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$26.2M -$6.36M +$597K +8.58% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$26.8M -$6.74M +$1.63M +19.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$28.4M -$2.76M +$3.21M +53.8% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 -$31.6M -$10.3M -$2.51M -32.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$29.1M -$6.96M -$2.59M -59.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$26.5M -$8.37M +$2.88M +25.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$29.4M -$5.97M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-14
Q3 2011 -$7.82M +$1.77M +18.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$4.37M +$670K +13.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$11.2M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$9.59M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$5.04M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.